Daejeon, South Korea

Hyeun Joung Lee

USPTO Granted Patents = 3 

Average Co-Inventor Count = 18.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Hyeun Joung Lee: Innovator in Anticancer Therapeutics

Introduction

Hyeun Joung Lee is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of innovative compounds for cancer treatment. With a total of 3 patents to his name, Lee's work focuses on enhancing the efficacy and safety of anticancer drugs.

Latest Patents

One of Lee's latest patents is a pyrrolobenzodiazepine dimer prodrug and a ligand-linker conjugate compound. This invention relates to a composition that is particularly useful as an anticancer drug. The compounds exhibit excellent stability both in themselves and in plasma, making them advantageous for targeting proliferative diseases such as cancer. This innovation aims to maximize drug efficacy while minimizing side effects.

Another significant patent involves an antibody-drug conjugate (ADC) that targets human ROR1. This invention includes methods for preparing such ADCs and their uses in treating diseases associated with the over-expression of ROR1, including various forms of cancer. The antibody-drug conjugate comprises an antibody that binds to ROR1, providing a promising avenue for therapeutic intervention.

Career Highlights

Hyeun Joung Lee has worked with notable companies in the biotechnology sector, including Legochem Biosciences, Inc. and Abl Bio Inc. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Lee has collaborated with esteemed colleagues such as Ho Young Song and Sung Min Kim. These partnerships have facilitated the advancement of his research and the successful development of his patented inventions.

Conclusion

Hyeun Joung Lee is a dedicated inventor whose work in the field of anticancer therapeutics has the potential to make a significant impact on cancer treatment. His innovative patents reflect a commitment to improving drug efficacy and safety, paving the way for future advancements in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…